Beovu, Made By Novartis, Earns A Recommendation From NICE
Following NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care. In the final form...
Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill
Could the Senate adopt a "watershed" bill allowing drug price discussions after years of government inaction regarding medication prices in the U.S.? Analysts are busy...
Arcutis Receives FDA Nod For Their Zoryve Psoriasis Cream
Pfizer previously held out hope that Eucrisa would become the trendiest topical treatment for inflammatory skin conditions. However, the ointment never took off because...
FDA Continues To Deal With Issues With Expedited Clearance
The use of excessively fragile efficacy data and delays in sponsors' presenting living proof from post-approval trials, as well as the approval of some...
FDA Scrutinises 2 Cancer Permits Sans Voluntary Withdrawals
The oncology division of the FDA has recently tightened regulations for expedited approvals and emphasised the significance of patient survival data. Several businesses promptly...
Azurity Gets FDA Nod On Liquid Epilepsy Drug After Rejection
On the second attempt, Azurity Pharmaceuticals was able to secure an FDA nod for its zonisamide oral suspension, making it the first firm to do...
Researchers Push For Antibiotic Nod In Brazil, India, And SA
According to a paper examining the present environment for antimicrobial development in Brazil, India, and South Africa, lowering regulatory barriers to hasten the clearance...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...